Volume 31, Issue Supplement_3
September 2000
ISSN 1058-4838
EISSN 1537-6591
Issue navigation
Volume 31, Issue Supplement_3, September 2000
Introduction
Immunology of Bacille Calmette-Guérin and Related Topics
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S59–S63, https://doi.org/10.1086/314063
Articles
Preventing Tuberculosis with Bacillus Calmette-Guérin Vaccine: A Meta-Analysis of the Literature
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S64–S67, https://doi.org/10.1086/314072
Animal Models for Experimental Tuberculosis
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S68–S70, https://doi.org/10.1086/314071
What Does Tuberculin Reactivity after Bacille Calmette-Guérin Vaccination Tell Us?
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S71–S74, https://doi.org/10.1086/314075
Management of Adverse Reactions to Bacille Calmette-Guérin Vaccine
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S75–S76, https://doi.org/10.1086/314074
An Analysis of Some Hypotheses Related to the Chingelput Bacille Calmette-Guérin Trial
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S77–S80, https://doi.org/10.1086/314073
The Bcg Host-Resistance Gene
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S81–S85, https://doi.org/10.1086/314067
Efficacy and Safety of Bacille Calmette-Guérin Immunotherapy in Superficial Bladder Cancer
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S86–S90, https://doi.org/10.1086/314064
Mechanisms of Action of Intravesical Bacille Calmette-Guérin: Local Immune Mechanisms
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S91–S93, https://doi.org/10.1086/314066
In Vitro Generation of Bacillus Calmette-Guérin-Activated Killer Cells
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S94–S100, https://doi.org/10.1086/314068
Reduction of Side Effects of Intravesical Therapy with Bacille Calmette-Guérin by Pentoxifylline?—An In Vitro Approach
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S101–S105, https://doi.org/10.1086/314069
Role of Animal Models in Understanding Intravesical Therapy with Bacille Calmette-Guérin
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S106–S108, https://doi.org/10.1086/314065
Immunostimulation in the Urinary Bladder by Local Application of Nocardia rubra Cell-Wall Skeletons (Rubratin) and Bacillus Calmette-Guérin as Therapy for Superficial Bladder Cancer: A Comparative Study
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S109–S114, https://doi.org/10.1086/314062
Discussion
Bacille Calmette-Guérin Vaccine
Clinical Infectious Diseases, Volume 31, Issue Supplement_3, September 2000, Pages S115–S121, https://doi.org/10.1086/314070
